MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”)(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Stem cell plays have cooled their jets since the news of Geron and Advanced Cell Technology becoming the first ...

Losses at Advanced Cell Technology (ACT) of Marlborough deepened in its first quarter, as the cost of clinical trials for its macular degeneration treatments rose, the company said. Advanced Cell ...

Avantor Inc. (NYSE:AVTR) is one of the best large cap stocks to buy under $20. On October 15, Avantor announced a partnership ...

MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, Inc., a biotechnology company with innovative transgenic technologies that simplify and accelerate antibody discovery, today announced a ...

Visionary Holdings Inc. ('GV' or the 'Company'), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the signing of a strategic cooperation agreement with ...

Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical ...